Akash Khobragade

Efficacy, safety, and immunogenicity of the DNA SARS-CoV-2 vaccine (ZyCoV-D): the interim efficacy results of a phase 3, randomised, double-blind, placebo-controlled study in India

Akash Khobragade, Suresh Bhate, Vijendra Ramaiah et al. · The Lancet · 2022 · 248 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Efficacy and safety of pegylated interferon-α2b in moderate COVID-19: a phase 3, randomized, comparator-controlled, open-label study

Shashi Bhushan B L, Sunil Wanve, Parshottam Koradia et al. · International Journal of Infectious Diseases · 2021 · 28 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +15

Safety and Immunogenicity of a novel three-dose recombinant nanoparticle rabies G protein vaccine administered as simulated post exposure immunization: A randomized, comparator controlled, multicenter, phase III clinical study

H S Ravish, Akash Khobragade, Durga Madhab Satapathy et al. · Human Vaccines & Immunotherapeutics · 2021 · 13 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Knowledge, attitude and practices of medical students and teachers towards clinical research in a tertiary care hospital in Mumbai and #8211; cross sectional survey

Dinesh Dhodi, Karan Thakkar, Gauri Billa et al. · Journal of Contemporary Medical Education · 2013 · 11 citations

Medicine, Clinical Sciences, Medical Education +13

Evaluation of the Safety and Efficacy of Favipiravir in Adult Indian Patients with Mild-to-Moderate COVID-19 in a Real-World Setting

Pavan Kumar Reddy, Saiprasad Patil, Akash Khobragade et al. · International Journal of General Medicine · 2022 · 10 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13